##DESCRIPTION=tumor_af=Mutant allele frequency in tumor (Sample GS150497_01).
##DESCRIPTION=tumor_dp=Tumor Depth (Sample GS150497_01).
##DESCRIPTION=normal_af=Mutant allele frequency in normal (Sample GS150496_01).
##DESCRIPTION=normal_dp=Normal depth (Sample GS150496_01).
##DESCRIPTION=filter=Filter criteria from vcf file.
##DESCRIPTION=snp_q=Quality parameters - SNP quality (QUAL).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, NM number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=interpro=Interpro domains.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=Kaviar=Allele frequency in Kaviar database.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen2=Polyphen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=FATHMM=FATHMM effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=som_ihdb_c=Somatic variant count within NGSD.
##DESCRIPTION=som_ihdb_p=Projects with somatic variant in NGSD.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Comments from the NGSD. Comments of other samples are listed in brackets!
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, ExAC pLI score).
##FILTER=fv.not_cod_spli=Not a coding or splicing variant (filter_vcf).
##FILTER=fv.off_target=Variant is off target (filter_vcf).
##FILTER=fv.somca_all_freq=Allele frequencies in tumor < 0.05 or allele frequencies in normal > 0.01 (filter_vcf).
##FILTER=fv.somca_db_frequencies=Allele frequencies in public databases are > 0.01 (filter_vcf).
##FILTER=fv.somca_depth_norm=Sequencing depth normal is too low < 100 (filter_vcf).
##FILTER=fv.somca_depth_tum=Sequencing depth tumor is too low < 100 (filter_vcf).
##FILTER=s.special_chromosome=Special chromosome.
#chr	start	end	ref	obs	tumor_af	tumor_dp	normal_af	normal_dp	filter	snp_q	gene	variant_type	coding_and_splicing	interpro	Pathway_KEGG_full	Function_description	Pathway_BioCarta_full	RepeatMasker	dbSNP	1000g	ExAC	Kaviar	COSMIC	OMIM	ClinVar	HGMD	phyloP	MetaLR	Sift	PolyPhen2	FATHMM	CADD	som_ihdb_c	som_ihdb_p	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info
chr8	38271515	38271515	T	C	0.4648	604	0.0000	291		604	FGFR1	missense_variant	FGFR1:NM_001174067.1:missense_variant:MODERATE:exon18/19:c.2306A>G:p.His769Arg,FGFR1:NM_001174065.1:missense_variant:MODERATE:exon17/18:c.2207A>G:p.His736Arg,FGFR1:NM_001174066.1:missense_variant:MODERATE:exon16/17:c.1946A>G:p.His649Arg,FGFR1:NM_001174063.1:missense_variant:MODERATE:exon17/18:c.2207A>G:p.His736Arg,FGFR1:NM_001174064.1:missense_variant:MODERATE:exon18/19:c.2183A>G:p.His728Arg,FGFR1:NM_015850.3:missense_variant:MODERATE:exon17/18:c.2207A>G:p.His736Arg,FGFR1:NM_023105.2:missense_variant:MODERATE:exon16/17:c.1946A>G:p.His649Arg,FGFR1:NM_023106.2:missense_variant:MODERATE:exon16/17:c.1940A>G:p.His647Arg,FGFR1:NM_023110.2:missense_variant:MODERATE:exon17/18:c.2213A>G:p.His738Arg	Serine-threonine/tyrosine-protein_kinase__2_,Protein_kinase-like_domain__1_,Tyrosine-protein_kinase__catalytic_domain__1_,Protein_kinase__catalytic_domain__1_	MAPK signaling pathway;Adherens junction;Regulation of actin cytoskeleton;Prostate cancer;Melanoma	Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation				0.0000	0.0000	0.0000		136350 [FGFR1 (confirmed) Pfeiffer syndrome,101600|Jackson-Weiss syndrome,123150|Hypogonadotropic hypogonadism 2 with or without anosmia,147950|Osteoglophonic dysplasia,166250|Trigonocephaly 1,190440|Hartsfield syndrome,615465|Encephalocraniocutaneous lipomatosis,613001];			4.896000	T	D,D,D,D,D,D,D,D,D,D,D	B,B,P,P,P	D,D,D,D,D,D,D,D,D,D,D	22.80	1	GT,	0	0			n/a	n/a	FGFR1 (inh=AD pLI=0.99)
chr9	98231134	98231134	C	T	0.1708	410	0.0000	374		203	PTCH1,LOC100507346	missense_variant,non_coding_transcript_exon_variant	PTCH1:NM_000264.3:missense_variant:MODERATE:exon14/24:c.2149G>A:p.Asp717Asn,PTCH1:NM_001083607.1:missense_variant:MODERATE:exon14/24:c.1696G>A:p.Asp566Asn,PTCH1:NM_001083606.1:missense_variant:MODERATE:exon14/24:c.1696G>A:p.Asp566Asn,PTCH1:NM_001083604.1:missense_variant:MODERATE:exon14/24:c.1696G>A:p.Asp566Asn,PTCH1:NM_001083605.1:missense_variant:MODERATE:exon14/24:c.1696G>A:p.Asp566Asn,PTCH1:NM_001083602.1:missense_variant:MODERATE:exon14/24:c.1951G>A:p.Asp651Asn,PTCH1:NM_001083603.1:missense_variant:MODERATE:exon14/24:c.2146G>A:p.Asp716Asn,LOC100507346:NR_038982.1:non_coding_transcript_exon_variant:MODIFIER:exon4/4:n.790C>T:		Hedgehog signaling pathway;Basal cell carcinoma	Acts as a receptor for sonic hedgehog (SHH), indian hedgehog (IHH) and desert hedgehog (DHH). Associates with the smoothened protein (SMO) to transduce the hedgehog's proteins signal. Seems to have a tumor suppressor function, as inactivation of this protein is probably a necessary, if not sufficient step for tumorigenesis	Sonic Hedgehog (Shh) Pathway;Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle			0.0000	0.0000	0.0000		601309 [PTCH1 (confirmed) Basal cell nevus syndrome,109400|Basal cell carcinoma,somatic,605462|Holoprosencephaly 7,610828];			7.192000	T	T,T,T,T,T,T,T,T	B,B,B,B	D,D,D,D,D,D,D	23.00	1	GT,	0	0			n/a	n/a	PTCH1 (inh=AD pLI=1.00), LOC100507346 (inh=n/a pLI=n/a)
chrX	48651570	48651570	G	A	0.9408	156	0.0000	137		650	GATA1	splice_region_variant&intron_variant	GATA1:NM_002049.3:splice_region_variant&intron_variant:LOW:exon4/5:c.745-9G>A:			Transcriptional activator which probably serves as a general switch factor for erythroid development. It binds to DNA sites with the consensus sequence [AT]GATA[AG] within regulatory regions of globin genes and of other genes expressed in erythroid cells	Hemoglobin's Chaperone		rs371005242	0.0000	0.00017492507376007	0.0001286		305371 [GATA1 (confirmed) Thrombocytopenia,X-linked,with or without dyserythropoietic anemia,300367|Leukemia,megakaryoblastic,with or without Down syndrome,somatic,190685|Thrombocytopenia with beta-thalassemia,X-linked,314050|Anemia,X-linked,with/without neutropenia and/or platelet abnormalities,300835];									1	GT,	0	0			n/a	n/a	GATA1 (inh=XLR pLI=0.84)
